These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
238 related articles for article (PubMed ID: 11839362)
41. Clinical magnetic resonance spectroscopy: a critical evaluation. Lenkinski RE Invest Radiol; 1989 Dec; 24(12):1034-8. PubMed ID: 2606632 [TBL] [Abstract][Full Text] [Related]
42. Applications of magnetic resonance spectroscopy to the investigation of neuropsychiatric disorders. Dager SR; Steen RG Neuropsychopharmacology; 1992 Jun; 6(4):249-66. PubMed ID: 1632893 [TBL] [Abstract][Full Text] [Related]
43. EEG mapping applications in psychiatric disorders. Williamson PC; Kaye H Can J Psychiatry; 1989 Oct; 34(7):680-6. PubMed ID: 2680048 [TBL] [Abstract][Full Text] [Related]
44. Magnetic Resonance Spectroscopy in Schizophrenia: Evidence for Glutamatergic Dysfunction and Impaired Energy Metabolism. Duarte JMN; Xin L Neurochem Res; 2019 Jan; 44(1):102-116. PubMed ID: 29616444 [TBL] [Abstract][Full Text] [Related]
45. Applications of functional MR imaging to research in psychiatry. Yurgelun-Todd DA; Renshaw PF Neuroimaging Clin N Am; 1999 May; 9(2):295-308. PubMed ID: 10318716 [TBL] [Abstract][Full Text] [Related]
46. Advanced In Vivo Heteronuclear MRS Approaches for Studying Brain Bioenergetics Driven by Mitochondria. Zhu XH; Du F; Zhang N; Zhang Y; Lei H; Zhang X; Qiao H; Ugurbil K; Chen W Methods Mol Biol; 2009; 489():317-57. PubMed ID: 18839099 [TBL] [Abstract][Full Text] [Related]
48. Brain bioenergetics and redox state measured by Chouinard VA; Kim SY; Valeri L; Yuksel C; Ryan KP; Chouinard G; Cohen BM; Du F; Öngür D Schizophr Res; 2017 Sep; 187():11-16. PubMed ID: 28258794 [TBL] [Abstract][Full Text] [Related]
49. Imaging based magnetic resonance spectroscopy (MRS) localization for quantitative neurochemical analysis and cerebral metabolism studies. Lee P; Adany P; Choi IY Anal Biochem; 2017 Jul; 529():40-47. PubMed ID: 28082217 [TBL] [Abstract][Full Text] [Related]
50. Quantitative proton-decoupled 31P MRS of the schizophrenic brain in vivo. Blüml S; Tan J; Harris K; Adatia N; Karme A; Sproull T; Ross B J Comput Assist Tomogr; 1999; 23(2):272-5. PubMed ID: 10096336 [TBL] [Abstract][Full Text] [Related]
51. Magnetic resonance imaging volumetric and phosphorus 31 magnetic resonance spectroscopy measurements in schizophrenia. Hinsberger AD; Williamson PC; Carr TJ; Stanley JA; Drost DJ; Densmore M; MacFabe GC; Montemurro DG J Psychiatry Neurosci; 1997 Mar; 22(2):111-7. PubMed ID: 9074305 [TBL] [Abstract][Full Text] [Related]
52. [Application of magnetic resonance spectroscopy in the study of brain disease]. Pérez-Gómez M; Junqué C; Mercader JM; Berenguer J Rev Neurol; 2000 Jan 16-31; 30(2):155-60. PubMed ID: 10730323 [TBL] [Abstract][Full Text] [Related]
53. Neuroimaging and psychiatry: the long road from bench to bedside. Mayberg HS Hastings Cent Rep; 2014; Spec No():S31-6. PubMed ID: 24634083 [TBL] [Abstract][Full Text] [Related]
54. [Advances in neuroimaging in schizophrenia: magnetic resonance spectroscopy]. Galińska B; Szulc A; Walecki J; Kubas B; Tarasów E Pol Merkur Lekarski; 2003 Sep; 15(87):278-80. PubMed ID: 14679857 [TBL] [Abstract][Full Text] [Related]
55. Images of the brain: past as prologue. Wagner HN J Nucl Med; 1986 Dec; 27(12):1929-37. PubMed ID: 3023564 [TBL] [Abstract][Full Text] [Related]
56. Magnetic resonance spectroscopy of the human brain. Ross B; Bluml S Anat Rec; 2001 Apr; 265(2):54-84. PubMed ID: 11323770 [TBL] [Abstract][Full Text] [Related]
57. Proton magnetic resonance spectroscopy changes after antipsychotic treatment. Szulc A; Galinska-Skok B; Waszkiewicz N; Bibulowicz D; Konarzewska B; Tarasow E Curr Med Chem; 2013; 20(3):414-27. PubMed ID: 23157634 [TBL] [Abstract][Full Text] [Related]
58. 31P NMR spectroscopy of phospholipid metabolites in postmortem schizophrenic brain. Komoroski RA; Pearce JM; Mrak RE Magn Reson Med; 2008 Mar; 59(3):469-74. PubMed ID: 18306399 [TBL] [Abstract][Full Text] [Related]